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The nonstructural small glycoprotein sGP, which unlike the transmembrane GP is synthesized from primary nonedited
mRNA species, is secreted from infected cells as a disulfide-linked homodimer. Site-directed mutagenesis of all cysteine
residues revealed that dimerization is due to an intermolecular disulfide linkage between cysteine residues at positions 53
and 306. Formic acid hydrolysis of sGP demonstrated that sGP dimers consist of monomers in antiparallel orientation.
Another editing product of the GP gene of Ebola virus (ssGP), which shares 295 amino-terminal amino acid residues with sGP,
is secreted from cells in a monomeric form due to the lack of the carboxyl-terminal part (present in sGP), including cysteine
at position 306. © 1998 Academic Press
INTRODUCTION
Ebola virus (EBOV), a member of the family Filoviridae
in the order Mononegavirales, is the etiological agent of
a severe hemorrhagic fever in humans and nonhuman
primates (Feldmann and Klenk, 1996; Peters et al., 1996).
The genome of EBOV codes for seven structural proteins:
the nucleocapsid-associated proteins nucleoprotein
(NP), virion protein (VP) 35, VP30, and RNA polymerase
(L); the transmembrane surface glycoprotein GP; and the
membrane-associated proteins VP40 and VP24 (Bukreyev
et al., 1993; Sanchez et al., 1992, 1993; Volchkov et al.,
1992). Recently it was shown that transmembrane GP,
the expression product of the GP gene after transcrip-
tional RNA editing (Sanchez et al., 1996; Volchkov et al.,
1995), is proteolytically processed and consists of the
disulfide-linked subunits GP1 and GP2 (Volchkov et al.,
1998a, 1998b). As shown for Marburg virus (MBGV) (Feld-
mann et al., 1991), the mature GP of EBOV is present in
the viral envelope as a homotrimer (Volchkov et al.,
unpublished data).
The nonstructural glycoprotein sGP, the primary prod-
uct of the GP gene of EBOV, is expressed from nonedited
mRNA species and efficiently secreted from infected
cells. It shares the N-terminal 295 amino acids (a.a.) with
the transmembrane GP but differs in the carboxyl termi-
nus by 69 a.a., suggesting differences in structure and
function of this protein (Sanchez et al., 1996; Volchkov et
al., 1995). Recently it was reported that recombinant sGP
binds to neutrophils, most likely through CD16b, and may
inhibit their activation (Yang et al., 1998). It has been
proposed that inhibition of the inflammatory response by
sGP, which is secreted in high amounts and detectable
in patient sera, is an important pathomechanism in Ebola
hemorrhagic fever.
To better understand the biological function of sGP,
detailed knowledge about the biochemical properties of
this protein is required. In this report, we demonstrate
that sGP is secreted as a homodimer. The oligomeric
structure is stabilized by a covalent linkage of monomers
in antiparallel orientation through cysteine at positions
53 and 306. In addition, we show that formation of sGP
dimers is the limiting step during synthesis and transport
of sGP.
RESULTS AND DISCUSSION
To investigate oligomerization of sGP, HeLa cells were
infected with a recombinant vaccinia virus (vSCGP7) car-
rying an exact copy of the EBOV GP gene and therefore
expressing sGP (Volchkov et al., 1995). At 18 h p.i., culture
supernatants and cell lysates were analyzed by SDS–
PAGE under reducing and nonreducing conditions fol-
lowed by immunodetection using anti-EBOV immuno-
globulins. Under reducing conditions, sGP migrated as a
55- to 60-kDa protein as described previously (Volchkov
et al., 1995). However, when nonreducing conditions
were applied, a 120- to 140-kDa protein was detected,
indicating a 2-mercaptoethanol-sensitive oligomeric form
of sGP, most likely a dimer (Fig. 1A).
The same results were obtained with sGP synthesized
and secreted from EBOV-infected Vero E6 cells (data not
shown). The formation of oligomers was further studied
by pulse-chase labeling and cross-linkage experiments.
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Infected cells were pulse-labeled for 20 min with [35S]-
cysteine and chased for 120 min, and culture superna-
tants were immunoprecipitated using anti-EBOV immu-
noglobulins. Under nonreducing conditions, only sGP
oligomers were detectable in culture medium, which
disassociated into the monomeric form under reducing
conditions (Fig. 1B). Secreted sGP contained mature
complex-type N-linked carbohydrates, whereas intracel-
lular sGP was found to be endo-H sensitive (Volchkov et
al., 1995). To determine the precise oligomeric structure,
sGP was digested with N-glycosidase F (PNGase F) after
cross-linkage with dimethyl pimelimidate (DMP). Under
this condition, oligomers are resistant to reducing agents.
This treatment reduced the molecular mass of the sGP
oligomers to 65–70 kDa compared with 35 kDa for the
monomeric form and gave final proof for the dimeric
structure of mature sGP (Fig. 1B).
To study the kinetics of sGP oligomerization, we used
monensin, which prevents transport from the endoplas-
mic reticulum (ER) to the Golgi compartments (Srinivas
et al., 1982). This treatment allowed examination of
ER-accumulated sGP dimers, which normally are trans-
ported into the Golgi apparatus, where they acquire
mature N-linked carbohydrates and subsequently are
efficiently secreted from cells. Pulse-chase experiments
in the presence of the transport inhibitor showed that a
remarkable part of sGP synthesized during 20-min pulse-
labeling remained monomeric and endo-H sensitive up
to 2 hr after synthesis (Fig. 2). A similar delay in dimer-
ization was also observed in the absence of monensin
(data not shown). Slow accumulation of sGP dimers
indicates that passage through the ER, the compartment
where Cys–Cys linkage and formation of oligomers nor-
mally occur, seems to be the limiting step during matu-
ration and transport of sGP.
In addition to sGP and transmembrane GP, another
nonstructural small GP (ssGP), is expressed from the GP
gene that was first described after in vitro expression of
EBOV GP using the T7 polymerase system (Volchkov et
al., 1995). ssGP is synthesized from edited GP-specific
mRNA containing nine or six adenosine residues at the
editing site. It shares the amino-terminal region with GP
and sGP but differs at the carboxyl terminus due to use
of a third (22) reading frame (Volchkov et al., 1995). The
resulting open reading frame is terminated two amino
acid residues downstream of the editing site and thus
resembles a natural carboxyl-terminal truncation variant
of sGP. Amino acid sequence analysis of sGP showed
eight cysteine residues (five at the amino-terminal end
and three at the carboxyl terminal end) that could be
involved in the linkage of sGP monomers. In contrast to
sGP, ssGP contained only five amino-terminal cysteine
residues (Fig. 3A). As with sGP, ssGP lacks a membrane
anchor region and therefore is secreted from infected
cells (Fig. 3B). Calculations of the deduced amino acid
sequences of sGP and ssGP indicated a molecular mass
difference of ;6.5 kDa. However, a smaller difference
was noticed after SDS–PAGE under reducing conditions
that was slightly increased after PNGase F treatment
(Fig. 3B, right).
In contrast to sGP, ssGP did not appear in an oligo-
meric form when analyzed under nonreducing conditions
(Fig. 3C). The small amount of the larger molecular mass
protein detected after transient expression of ssGP rep-
resented sGP dimers (Fig. 3C, lane 5) that were synthe-
sized due to the editing activity of T7 polymerase (Volch-
kov et al., 1995). Cross-linkage of released ssGP by DMP
did not result in the appearance of an oligomeric form.
These suggest that the carboxyl terminus of sGP is
obligatory for its oligomerization (Fig. 3). To examine the
role of the three carboxyl-terminal cysteine residues of
sGP in oligomerization, we substituted each of them with
glycine residues using site-specific mutagenesis. All mu-
tants were evaluated for secretion and oligomerization
FIG. 1. EBOV sGP is secreted as a homodimer. (A) Immunoblot
analysis. HeLa cells were infected with the recombinant vaccinia virus
vSCGP7. At 18 h p.i., cultural supernatant was collected, separated by
10% SDS–PAGE under reducing or nonreducing conditions, and blotted
onto a PVDF membrane. Detection of GP-specific proteins was per-
formed with goat anti-EBOV immunoglobulins. The positions of the
monomeric and oligomeric sGP are indicated. (B) Endoglycosidase
digestion of cross-linked sGP. HeLa cell monolayers were infected with
vSCGP7; at 4 h posttransfection, cells were labeled with [35S]cysteine
for 20 min and subsequently chased for 120 min. Labeled proteins from
culture medium were cross-linked using DMP and immunoprecipitated
using goat anti-EBOV immunoglobulins (1:100). Immunoprecipitated
sGP was treated with PNGase F and subjected to 10% SDS–PAGE
under reducing or nonreducing conditions.
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by transient expression in HeLa cells. Analysis of culture
supernatants by SDS–PAGE under nonreducing condi-
tions demonstrated that mutants C353G and C362G were
secreted as dimers as shown before for wildtype sGP. In
contrast, analysis of mutant C306G with or without cross-
linkage resulted in the synthesis of sGP monomers that
were efficiently secreted as wildtype sGP (Figs. 3B and
3C). These data indicated that sGP molecules are linked
by a disulfide bond involving the cysteine residue at
position 306.
To investigate the involvement of the five amino-termi-
nal cysteine residues in oligomerization of sGP, we sub-
stituted all cysteine by glycine residues. Transient ex-
pression in HeLa cells showed that except for mutant
C53G, all others were not secreted to detectable levels.
Analysis of cell lysates under nonreducing conditions
revealed that most of the synthesized sGP formed high
molecular mass aggregates, most likely due to incorrect
folding. Synthesis of sGP was confirmed in all cases by
detection of the monomeric molecules under reducing
conditions (data not shown). Expression of mutant C53G
resulted in secretion of sGP dimers. These dimers, how-
ever, migrated faster on a nonreducing SDS–polyacryl-
amide gel (110–120 kDa) than wildtype sGP dimers (130–
140 kDa) (Fig. 4A, right). In addition, small amounts of
sGP monomers were found in the medium. These data
suggested a particular role of cysteine residue at posi-
tion 53 in sGP oligomerization.
To further examine the oligomeric structure of sGP, we
performed chemical hydrolysis with formic acid. This
treatment generated two indistinguishable fragments of
;25–26 kDa through cleavage of sGP monomers at the
single Asp–Pro bond located at positions 208–209 (Fig.
4B, left). Under reducing conditions, these fragments
were detected with sGP of wildtype as well as mutants
C306G and C53G. Hydrolysis was incomplete in all these
cases as indicated by remaining uncleaved sGP mono-
mer. With the application of nonreducing conditions, mu-
tant C306G showed a similar polypeptide pattern (Fig. 4B,
right). As already known from previous experiments (see
also Fig. 1), anti-EBOV immunoglobulins recognize sGP
more efficiently when analyzed under nonreducing con-
ditions. Analysis of wildtype sGP resulted in the appear-
ance of two major bands, a polypeptide migrating slightly
slower than sGP and noncleaved sGP dimer, but no
detection of the hydrolysis fragments of 25–26 kDa (Fig.
4B, right). This result can be explained only by a linkage
of two distinct hydrolysis fragments of different mono-
mers. Taken into consideration that cysteine at positions
108, 121, 135, and 147 was not involved in oligomeriza-
tion, these results suggest that wildtype sGP dimers
consist of monomers in antiparallel orientation that are
intermolecularly disulfide linked by cysteine residues at
positions 53 and 306 (Fig. 5). Cysteine at position 306 is
obligatory for oligomerization, as indicated by the lack of
sGP dimerization of mutant C306G. The absence of
dimerization with mutant C306G and ssGP further dem-
onstrated that no disulfide bonds were formed between
the cysteine residues at position 53, which supported the
concept of antiparallel-orientated molecules in sGP
dimers (Fig. 5). In contrast, hydrolysis of sGP of mutant
FIG. 2. Dimerization is the limiting step during maturation of sGP. At
6 h p.i. (vSCGP7), HeLa cells were pulse-labeled for 20 min (lane 0) in
either the absence or presence of the ionophor inhibitor monensin
(1026 M) and chased for the indicated time intervals. Lysed cells and
culture medium were immunoprecipitated with goat anti-EBOV immu-
noglobulins. (A and B) Kinetics of EBOV sGP dimerization. Precipitated
proteins were separated on 10% polyacrylamide gels under reducing
(A) or nonreducing (B) conditions and visualized by fluorography. (C)
Endoglycosidase digestion of sGP. Immunoprecipitated proteins from
cell lysates and culture medium were treated with endo H and subse-
quently separated on 10% polyacrylamide gels. Mature sGP, which was
synthesized only in the absence of monensin, displayed endo H resis-
tance and was released into culture medium. The positions of the
monomeric and dimeric forms of sGP are indicated. Note: Two forms of
sGP were detected intracellularly. The endo H-sensitive precursor
present in the endoplasmic reticulum has been designated sGPer. sGP
represents the mature form in the Golgi apparatus that is secreted into
culture medium (endo H resistant).
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C53G revealed three bands: the 25- to 26-kDa fragments,
the polypeptide migrating slightly slower than sGP
monomer, and noncleaved sGP dimer with abnormal
SDS–PAGE mobility (see above). These data suggested
that in molecules lacking cysteine at position 53, dimer-
ization may be possible due to intermolecular disulfide
linkage between cysteine residues at position 306. This,
however, may lead to structural alterations and abnormal
electrophoretic mobility of dimeric molecules as ob-
served here (Fig. 4). The detection of secreted mono-
meric sGP in this case demonstrated either an inefficient
oligomerization process or a reduced stability of this
FIG. 3. Carboxyl-terminal cysteine residue at position 306 is involved in sGP dimerization. (A) Schematic representation of sGP and ssGP. The
numbers indicate the positions of cysteine residues. The black box in ssGP represents the three distinct carboxyl-terminal amino acid residues
compared with sGP that are derived by utilization of a different ORF. (B) Transient expression of ssGP compared with sGP. HeLa cell monolayers were
infected with the recombinant vaccinia virus vTF7–3 followed by transfection with pGEM-mGP7 or pGEM-GP9. At 18 h posttransfection, culture
supernatants were collected, divided in two parts, and analyzed on 10% SDS–polyacrylamide gels before (left) or after (right) PNGase F digestion.
Detection of GP-specific proteins was performed with goat anti-EBOV immunoglobulins. (C) Oligomeric structures of ssGP and sGP mutants C306G,
C353G, and C362G. HeLa cells were infected with vTF7–3 followed by transfection with pGEM-C306G (lane 1), pGEM-C353G (lane 2), pGEM-C362G (lane
3), pGEM-mGP7 (lane 4), or pGEM-mGP9 (lane 5). At 4 h posttransfection, cells were labeled with [35S]cysteine for 20 min and chased for 120 min.
Immunoprecipitated (goat anti-EBOV immunoglobulins, 1:100) labeled soluble proteins from culture medium were subjected to 10% SDS–PAGE under
nonreducing conditions (left) or after cross-linkage by DMP under reducing conditions (right). Note: The small amount of sGP dimers observed after
expression of pGEM-mGP9 is explained by the RNA editing activity of T7 polymerase (Volchkov et al., 1995).
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specific abnormal disulfide linkage. An antiparallel orga-
nization of dimers has been described for members of
the growth factor family, such as vascular permeability
factor or platelet-derived growth factor (Andersson et al.,
1992; Potgens et al., 1994). It is interesting to note that
with these proteins also, the substitution of one of two
cysteine residues involved in the antiparallel interchain
disulfide bonds led to formation of abnormal dimers.
The data presented here support the concept that
synthesized sGP remains in association with ER-resident
cellular proteins involved in folding and is transported to
the Golgi compartments only after the formation of Cys–
Cys linkages. In this respect, the interaction of the pro-
tein disulfide isomerase (PDI), which catalyzes intramo-
lecular and intermolecular Cys–Cys bonds (Freedman et
al., 1989), with cysteine residue at position 306 may be
the first step in sGP oligomerization. Cysteine at position
53 of a different monomer may then be available for
disulfide linkage resulting in sGP dimers of antiparallel
orientation. Both cysteine residues do not seem to be
essential for correct intramolecular folding of sGP mono-
mers, as indicated by the efficient sGP secretion of
mutants C53G and C306G. The four amino-terminal cys-
teine residues at positions 108, 121, 135, and 147, how-
ever, seem to be directly involved in intramolecular fold-
ing of monomers because their substitution resulted in
protein aggregation and block of transport. This is in
agreement with observations made with cysteine mu-
tants of other oligomeric viral glycoproteins, such as NS1
of Dengue virus (Pryor and Wright 1993), HA of influenza
virus (Segal et al., 1992), and G of VSV (de Silva et al.,
1990). For all of them, it was shown that due to incorrect
folding, they become associated with resident cellular
proteins, form aggregates, and eventually are degraded
(Doms et al., 1993). Obviously, the two cysteine residues
at positions 353 and 362 are involved in neither intramo-
lecular nor intermolecular sGP folding as indicated by
the efficient secretion of dimeric sGP after expression of
mutants C353G and C362G. Dimerization involving Cys–
Cys bonds at position 53 and 306 appears to be con-
trolled very precisely because predominantly dimers in
antiparallel orientation were secreted from cells. The
important role of the cysteine residues for sGP structure
and function is further supported by their conservation
among all known subtypes of Ebola virus.
MATERIALS AND METHODS
Cells and viruses
The EBOV strain Eckron, subtype Zaire, was received
from the Institute Voor Tropische Geeneskunde (An-
twerp, Belgium). This virus strain, as EBOV strain May-
inga, was isolated from a case of the 1976 outbreak of
Ebola hemorrhagic fever in Zaire (S. R. Pattyn, personal
communication) and represents a wildtype strain (EBOV-
7U) with an editing site of seven consecutive uridine
residues (GenBank accession number U81161; Volchkov
et al., 1997). The recombinant vaccinia virus expressing
T7 polymerase (vTF7–3) was kindly provided by B. Moss
(National Institutes of Health, Bethesda, MD). The recom-
binant vaccinia virus expressing EBOV sGP (vSCGP7)
was described previously (Volchkov et al., 1995). EBOV,
strain Eckron, was propagated in Vero cells (clone E6)
and the recombinant vaccinia viruses in CV-1 cells. Vero,
CV-1, and HeLa cells (transient expression, see below)
were maintained in Dulbecco’s modified Eagle’s medium
containing 10% FCS (GIBCO).
Recombinant plasmids for transient expression
The construction of plasmid pGEM-mGP9, which di-
rects synthesis of the GP-specific mRNA with nine aden-
osine residues at the editing site and therefore ex-
presses ssGP, was described previously (Volchkov et al.,
FIG. 4. sGP dimers show an antiparallel orientation. HeLa cells were
infected with vTF7–3 at an m.o.i. of 10 and followed by transfection with
plasmids pGEM-C53G, pGEM-C306G, and pGEM-mGP7. At 18 h post-
transfection, culture media were clarified by low-speed centrifugation
and subjected to 10% SDS–PAGE under reducing (left) or nonreducing
(right) conditions before (A) or after (B) treatment with formic acid.
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1995). To generate the different cysteine2minus mutants
of sGP (pGEM-C53G, pGEM-C108G, pGEM-C121G, pGEM-
C135G pGEM-C147G, pGEM-C306G, pGEM-C353G, and
pGEM-C362G), polymerase chain reaction (PCR) mu-
tagenesis of the previously described plasmid pGEM-
mGP7 (Volchkov et al., 1995) was performed using the
Quick-Change Kit (Stratagene). All clones were verified
by sequence determination. Transient expression in
HeLa cells using the vaccinia/T7 polymerase expression
system and immunoblot and immunoprecipitation analy-
ses were carried out as described previously (Volchkov
et al., 1995, 1998a).
Cross-linking
Protein cross-linkage using dimethyl pimelimidate
(DMP) was performed according to the instruction of the
supplier (Pierce). Briefly, culture supernatants containing
sGP (250 ml) were clarified by low-speed centrifugation
(1500g, 10 min, 4°C) and mixed with an equal volume of
dinatriumtetraborate decahydrate (200 mM, pH . 8.3)
containing DMP (final concentration 20 mM). After incu-
bation at room temperature for 30 min, the reaction was
stopped by the addition of 1 M glycine (final concentra-
tion 100 mM). Samples were analyzed for the presence
of sGP using either immunoprecipitation or immunoblot
techniques (Volchkov et al., 1998a).
Chemical hydrolysis
Hydrolysis of sGP with formic acid, which cleaves the
protein at the Asp–Pro bond at position 208–209, was
carried out as described previously (Zhirnov and Klenk,
1997). Briefly, culture supernatants containing sGP were
clarified by low-speed centrifugation (1500g, 10 min, 4°C)
and treated with formic acid at a final concentration of
70% in the presence of 10 mM iodoacetamide. After an
incubation at 37°C for 60 h, formic acid was evaporated,
and samples were dissolved in 20 mM Tris–HCl, pH 8.7,
and analyzed for the presence of sGP fragments under
reducing and nonreducing conditions using an immuno-
blot technique (Volchkov et al., 1995).
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